Category

NASDAQ

BioNexus Gene Lab Becomes First Nasdaq-Listed Firm to Prioritize Ethereum in Treasury Strategy NASDAQ

BioNexus Gene Lab Becomes First Nasdaq-Listed Firm to Prioritize Ethereum in Treasury Strategy

BioNexus Gene Lab (BGLC) has adopted an Ethereum-focused treasury strategy, thus becoming the first Nasdaq-listed company to prioritize ETH. The exact percentage for its Ethereum allocation has not been divulged by the company but the move follows the leading altcoin’s inclusion in the US “Crypto Strategic Reserve.” BGLC Embraces Ethereum…
bubmag
May 5, 2025
Bessent says correction “healthy” for markets that had been “euphoric” NASDAQ

Bessent says correction “healthy” for markets that had been “euphoric”

Treasury Secretary Scott Bessent on Sunday said the correction in the S&P 500 and Nasdaq was "healthy," and suggested that prior strong performance in stocks had been signs of a "euphoric" market.Why it matters: Treasury secretaries don't typically welcome major stock indices falling 10% in less than a month.But Bessent…
bubmag
March 16, 2025
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease NASDAQ

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease

BETHESDA, MD, Mar 14, 2025 - (ACN Newswire) - Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced the dosing of the first participant with Parkinson’s disease (PD) in its…
bubmag
March 14, 2025